Skip to content

LEDGER2026 YTD $21.4B253 roundslast Oct 20, 2026

Series A

Converge Bio raises $25M Series A

$25M

By Israel Rounds desk. Edited by Eliran Yihye. Published . Updated .

Converge Bio raised $25M in a Series A round1, announced Jan 13, 20261, led by Bessemer Venture Partners1.

Also participating: TLV Partners, Vintage Investment Partners and Saras Capital1.

Lead investor

  • Bessemer Venture Partners

Also participating

  • TLV Partners
  • Vintage Investment Partners
  • Saras Capital

Sources

  1. 1CTech, Jan 13, 2026. “Converge Bio raises $25 million Series A to accelerate AI drug discovery”

How much did Converge Bio raise in its Series A?

Converge Bio raised $25M in its Series A, announced Jan 13, 2026.

Who led Converge Bio’s Series A?

The round was led by Bessemer Venture Partners.

Which investors took part in Converge Bio’s Series A?

Participants: Bessemer Venture Partners, TLV Partners, Vintage Investment Partners and Saras Capital.

How much has Converge Bio raised in total?

Converge Bio has raised $25M across 1 recorded round.